- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
4726
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Mycenax Biotech Inc. · Healthcare · Biotechnology
Latest close
24.50 TWD
0.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -15.7% below the Trend Line and sits at 4.3% of its 52-week range. The latest completed week returned 0.6%, after a 0.0% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
19
out of 100
Latest Close
24.50 TWD
14 Aug 2026
1W Return
0.6%
latest completed week
4W Return
0.0%
short-term follow-through
12W Return
-14.3%
quarterly tape
Trend Breadth
5.8%
3 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.6%
Latest completed week; four-week move 0.0%.
Indicator stack
3/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.29%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -15.7% below the Trend Line and sits at 4.3% of its 52-week range. The latest completed week returned 0.6%, after a 0.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.0% over four weeks, -14.3% over 12 weeks, and -33.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year3
Trend breadth5.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.93Latest activity-pressure read.
Pressure change23.8%Four-week change in activity pressure.
Leadership-46.24Latest relative-leadership reading.
RS change0.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.8%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+10.6%Week of 3 Jul.
Worst week-7.3%Week of 12 Jun.
Latest week+0.6%Week of 14 Aug.
Shape of recent returns
Strong gains1
Modest gains7
Flat weeks0
Modest losses14
Sharp losses4
Recent vol4.4%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split18/33Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank54 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank36 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape16/100
Trend, activity pressure, participation, and risk combine to a 16/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 40.29%Next-week expectancy is negative with a 40.29% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 24.50 TWD | 0.6% | 29.08 TWD | 38.47 TWD | -0.93 | -46.24 | 721.0K | Off |
| 7 Aug 2026 | 24.35 TWD | 0.6% | 29.43 TWD | 38.59 TWD | -1.14 | -45.70 | 604.0K | Off |
| 31 Jul 2026 | 24.20 TWD | -3.0% | 29.68 TWD | 38.71 TWD | -1.25 | -45.74 | 797.1K | Off |
| 24 Jul 2026 | 24.95 TWD | 1.8% | 29.89 TWD | 38.83 TWD | -1.17 | -45.84 | 513.2K | Off |
| 17 Jul 2026 | 24.50 TWD | -4.5% | 30.11 TWD | 38.93 TWD | -1.22 | -46.66 | 831.5K | Off |
| 10 Jul 2026 | 25.65 TWD | -3.4% | 30.37 TWD | 39.05 TWD | -1.29 | -48.51 | 620.8K | Off |
| 3 Jul 2026 | 26.55 TWD | 10.6% | 30.60 TWD | 39.16 TWD | -1.26 | -49.33 | 1.4M | Off |
| 26 Jun 2026 | 24.00 TWD | -4.8% | 30.81 TWD | 39.25 TWD | -1.31 | -52.86 | 1.5M | Off |
| 19 Jun 2026 | 25.20 TWD | -0.6% | 31.07 TWD | 39.37 TWD | -1.22 | -53.46 | 942.0K | Off |
| 12 Jun 2026 | 25.35 TWD | -7.3% | 31.34 TWD | 39.48 TWD | -1.14 | -51.73 | 1.8M | Off |
| 5 Jun 2026 | 27.35 TWD | 0.7% | 31.60 TWD | 39.57 TWD | -1.08 | -50.00 | 1.7M | Off |
| 29 May 2026 | 27.15 TWD | -5.1% | 31.81 TWD | 39.65 TWD | -1.09 | -50.94 | 1.6M | Off |
| 22 May 2026 | 28.60 TWD | 1.2% | 32.04 TWD | 39.72 TWD | -1.19 | -46.34 | 830.2K | Off |
| 15 May 2026 | 28.25 TWD | -1.1% | 32.26 TWD | 39.78 TWD | -1.11 | -46.29 | 2.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.